Compare AVAH & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVAH | HTGC |
|---|---|---|
| Founded | 1984 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.0B |
| IPO Year | 2021 | 2004 |
| Metric | AVAH | HTGC |
|---|---|---|
| Price | $11.01 | $15.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | $15.20 | ★ $19.50 |
| AVG Volume (30 Days) | ★ 2.1M | 1.5M |
| Earning Date | 11-12-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 12.38% |
| EPS Growth | ★ 1850.00 | 14.91 |
| EPS | 0.57 | ★ 1.39 |
| Revenue | ★ $2,433,199,000.00 | N/A |
| Revenue This Year | $11.36 | $9.11 |
| Revenue Next Year | $7.58 | $8.84 |
| P/E Ratio | $18.81 | ★ $10.91 |
| Revenue Growth | ★ 20.19 | N/A |
| 52 Week Low | $5.93 | $13.70 |
| 52 Week High | $14.71 | $19.13 |
| Indicator | AVAH | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 31.53 | 24.91 |
| Support Level | $8.91 | $13.77 |
| Resistance Level | $13.76 | $15.89 |
| Average True Range (ATR) | 0.71 | 0.33 |
| MACD | -0.28 | -0.11 |
| Stochastic Oscillator | 11.22 | 0.54 |
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.